Aryl iodides
Medchemexpress LLC MyoMed 205 | 2614161-13-4 | 98.0% | 491.56 g/mol | C26H25N3O5S | 10 MG
MyoMed 205 is a small-molecule inhibitor of MuRF1 supplied as a white to off-white solid for research use. It reduces ubiquitination and proteasomal degradation of muscle proteins and has been used in preclinical studies to prevent early diaphragmatic systolic dysfunction and muscle atrophy. Recommended handling includes storage of the powder at low temperature and preparation of solutions in DMSO with warming as needed.
- Small-molecule MuRF1 inhibitor for research use.
- White to off-white solid with high reported purity.
- Soluble in DMSO at up to 25 mg/mL with sonication and warming.
- Formulatable for in vivo dosing in 10% DMSO/90% corn oil at ≥ 2.5 mg/mL.
- Store powder at -20°C for long-term stability.
eMolecules 5-Bromo-2-iodo-benzoyl chloride | 293738-03-1 | MFCD02063081 | 1g
Oakwood Chemicals | 5-Bromo-2-iodo-benzoyl chloride | 1g | 480165139 | 246343 | | 293738-03-1 | MFCD02063081 | 345.360 | C7H3BrClIO
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules Pharmablock 4-iodopyridine 500mg 788522005 PBRL062 0 000 15854-87-2 MFCD02093937 204 998 C5H4IN
Pharmablock 4-iodopyridine 500mg 788522005 PBRL062 0 000 15854-87-2 MFCD02093937 204 998 C5H4IN
eMolecules Synthonix 2-Bromo-5-iodo-1 3-dimethylbenzene 250mg 649424016 B48771 0 000 689260-53-5 MFCD07780650 310 960 C8H8BrI
Synthonix 2-Bromo-5-iodo-1 3-dimethylbenzene 250mg 649424016 B48771 0 000 689260-53-5 MFCD07780650 310 960 C8H8BrI
eMolecules Pharmablock tert-butyl 6-iodo-2-azaspiro[3 3]heptane-2-carboxylate 500mg 713714201 PBXH381 0 000 2059140-61-1 323 174 C11H18INO2
Pharmablock tert-butyl 6-iodo-2-azaspiro[3 3]heptane-2-carboxylate 500mg 713714201 PBXH381 0 000 2059140-61-1 323 174 C11H18INO2
TARGETMOL CHEMICALS INC A 1120 10MG
Also available in 1 mL, 1 mg, 2 mg, 5 mg, 25 mg, 50 mg, 100 mg, 500 mg and bulk. Please contact Fisher for quotes. A 1120 is a nonretinoid retinol-binding protein 4 (RBP4) antagonist (Ki 8.3 nM), which disrupts the interaction between RBP4 and its binding partner transthyretin. Purity 99.11%
